ArticleJournal of translational medicine2025
Essential roles of DCAF7/WDR68 in mouse embryonic development.
Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundDCAF7/WDR68 (hereafter WDR68) is a highly conserved WD40 repeat protein across species and its role in mouse embryonic development is still unknown.
methodsThe mice deficient in WDR68 function by gene targeting were generated for its functional research. Several single-cell RNA-sequencing datasets that collectively span mouse gastrulation and organogenesis were integrated for reconstruction of expression trajectory of WDR68 spanning mouse embryogenesis. Weighted gene co-expression network analysis (WGCNA) was used for functional enrichment of co-expression genes of WDR68 in early embryos. Whole-embryo transcriptomic analyses were employed to reveal differentially expressed genes in WDR68-knockout mouse embryos. Co-immunoprecipitation in combination with liquid chromatography-mass spectrometry analysis was performed to examine the interacting proteins of WDR68.
resultsWDR68 null mutants exhibited intrauterine growth retardation (IUGR) and died during gestation. Mechanistically, WDR68 deficiency resulted in deregulated expression of development-related genes and activated Hypoxia-inducible factor-1 (HIF-1) pathway. The interactomics confirmed that WDR68 interacts with development-related proteins including AUTS2 and PCGF5.
conclusionsWDR68 is required for mouse embryonic development and may be a potential target for prevention and treatment of intrauterine growth retardation in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.